Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7,969Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 18BOEHRINGER INGELHEIM

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 10154990

Drug Substance Claim :

Drug Product Claim :

Application Number : 205832

Patent Use Code : U-2620

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-08

blank

02

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 10154990

Drug Substance Claim :

Drug Product Claim :

Application Number : 205832

Patent Use Code : U-2620

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-08

blank

03

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 9907756

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-07

blank

04

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 7119093

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-02-21

blank

05

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 10105323

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-04

blank

06

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 10105323

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-04

blank

07

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 6762180

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-01

blank

08

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 6762180

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-01

blank

09

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 9907756

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-06-07

blank

10

arrow
American Pharma Summit
Not Confirmed
arrow
American Pharma Summit
Not Confirmed

NINTEDANIB ESYLATE

US Patent Number : 7119093

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205832

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-02-21

blank